Auditory Stimulation for Rolandic Epilepsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to help children with Rolandic epilepsy by using auditory stimulation (a type of therapy using sound) during naps. Researchers aim to identify which brain areas are affected in children with this type of epilepsy compared to those without it, using brain imaging techniques like MRI and EEG. They hope the study will lead to better treatments for childhood epilepsy. Children aged 4 to 18 with Rolandic epilepsy who experience seizures might be suitable candidates for this study. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance future treatments for childhood epilepsy.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that auditory stimulation is safe for children with epilepsy?
Research has shown that playing sounds while children with Rolandic epilepsy sleep can reduce certain brain activities linked to this condition. Rolandic epilepsy, also known as benign epilepsy with centrotemporal spikes, is common in children and usually resolves by the teenage years. Using sound during sleep is non-invasive, meaning it doesn't involve surgery or entering the body, and children generally tolerate it well. Studies have not reported any major side effects from using sound in similar situations, suggesting it is a safe option for children with this condition.12345
Why are researchers excited about this trial?
Researchers are excited about using auditory stimulation for rolandic epilepsy because it introduces a non-invasive and innovative approach that differs from traditional treatments like anti-seizure medications. Unlike medications that alter brain chemistry, this method uses closed-loop auditory stimulation during naps to potentially regulate brain activity in a natural and gentle way. The hope is that this technique can reduce seizure frequency without the side effects associated with drugs, offering a safe alternative for children and adolescents with epilepsy.
What evidence suggests that auditory stimulation is effective for Rolandic epilepsy?
Research has shown that playing sounds while children with Rolandic epilepsy sleep can help reduce unusual brain activity. These unusual activities, called interictal spikes, originate from parts of the brain involved in communication. This trial will investigate the effects of auditory stimulation during sleep on these interictal spikes. Studies suggest that reducing these spikes might lower the risk of learning and thinking problems linked to this type of epilepsy. By reducing these spikes, sound therapy might improve the overall brain health of affected children. Although this method is new, early results indicate it could be a promising way to manage symptoms of Rolandic epilepsy.16789
Who Is on the Research Team?
Catherine J Chu, MD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for children aged 4-18 with Rolandic epilepsy, who've had at least one seizure and show specific brain activity patterns on an EEG. It's not for those with abnormal MRIs, other neurological diseases, metal implants or braces, claustrophobia, a history of frequent vomiting, or over the MRI weight limit.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Experimental Task and Imaging
Participants undergo MRI, MEG/EEG, and training on a memory task with auditory stimulation during a nap
Follow-up
Participants are monitored for safety and effectiveness after the experimental tasks
What Are the Treatments Tested in This Trial?
Interventions
- Auditory stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Boston University
Collaborator